Fig. 4: Suggested pathway for identification and management of hypertension in children and adolescents with Turner syndrome <18 years of age.
From: The prevalence of hypertension in paediatric Turner syndrome: a systematic review and meta-analysis
BP blood pressure, ABPM ambulatory blood pressure monitoring, CoA coarctation of the aorta, BAV bicuspid aortic valve, ACE angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker.
